Reversal of histamine-mediated immunosuppression by structurally diverse histamine type II (H2) receptor antagonists
- 1 January 1984
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 6 (5) , 467-473
- https://doi.org/10.1016/0192-0561(84)90085-7
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Mitogen stimulation of peripheral blood lymphocytes of duodenal ulcer patients during treatment with cimetidine or ranitidine.Gut, 1982
- INHIBITION OF LYMPHOCYTE PROLIFERATION BY HISTAMINE AND RELATED COMPOUNDS NOT MEDIATED VIA H1‐ OR H2‐ RECEPTORSBritish Journal of Pharmacology, 1981
- IN VIVO CIMETIDINE AUGMENTATION OF PHYTOHEMAGGLUTININ-INDUCED HUMAN LYMPHOCYTE THYMIDINE UPTAKETransplantation, 1981
- Histamine-induced suppressor cells of lymphocyte mitogenic responseCellular Immunology, 1981
- Effect of histamine on the mitogenic response of human lymphocytes and its modification by cimetidine and levamisoleInflammation Research, 1981
- Cimetidine abrogates suppressor T cell function in vitroImmunology Letters, 1981
- The effect of the major mediators of type I hypersensitivity on lymphocytes from normal and atopic subjectsInternational Journal of Immunopharmacology, 1980
- Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.Gut, 1980
- Inhibition of the Histamine-Stimulated Gastric Secretion in Healthy Subjects by the H2-Receptor Antagonist RanitidineScandinavian Journal of Gastroenterology, 1980
- CIMETIDINE-INDUCED AUGMENTATION OF HUMAN LYMPHOCYTE BLASTOGENESIS BY MITOGEN, BACTERIAL ANTIGEN, AND ALLOANTIGENTransplantation, 1980